Last $179.94 USD
Change Today +0.49 / 0.27%
Volume 1.4M
ILMN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 5:20 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc A. Stapley

Chief Financial Officer and Senior Vice President, Illumina Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

44$2,220,805
As of Fiscal Year 2013

Background*

Mr. Marc A. Stapley has been the Chief Financial Officer and Senior Vice President of Illumina Inc. since 2012 and served as its Principal Accounting Officer until January 1, 2013. Mr. Stapley served as Senior Vice President at Pfizer and was responsible for global financial processes and systems, leading integration efforts in both the Wyeth and King Pharmaceutical acquisitions and providing oversight to its largest technology investment program. Prior to Pfizer, he ...

Read Full Background

Corporate Headquarters*

5200 Illumina Way
San Diego, California 92122

United States

Phone: 858-202-4500
Fax: 858-202-4766

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Salary$447,749
Total Annual Compensation$447,749

Stock Options*

Restricted Stock Awards$1,472,517
All Other Compensation$12,465
Exercised Options45,497
Exercised Options Value$1,121,396
Exercisable Options19,909
Exercisable Options Value$1,474,859
Unexercisable Options71,094
Unexercisable Options Value$5,266,644
Total Value of Options$7,862,898
Total Number of Options136,500

Total Compensation*

Total Annual Cash Compensation$748,288
Total Short Term Compensation$447,749
Other Long Term Compensation$1,484,982
Total Calculated Compensation$2,220,805
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILMN:US $179.94 USD +0.49

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.2M
Frederic Roch Doliveux DVMChief Executive Officer and Executive Director
UCB SA
€2.1M
Hock E. Tan Chief Executive Officer, President and Executive Director
Avago Technologies Limited
$781.7K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILLUMINA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.